AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involutionAmy E. Schade, Karen Cichowski, Yoona Yang et al.|Nature|2024Cited by 56
Supplementary Methods S1 from Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing CancersJason J. Zoeller, Puja Sapra|Unknown|2025Cited by 0